Subtopic Deep Dive

Tissue Inhibitors of Metalloproteinases Regulation
Research Guide

What is Tissue Inhibitors of Metalloproteinases Regulation?

Tissue Inhibitors of Metalloproteinases (TIMP) regulation encompasses the molecular mechanisms controlling TIMP gene expression, protein secretion, and interactions with matrix metalloproteinases (MMPs) to balance extracellular matrix remodeling.

TIMPs include four main family members (TIMP-1 to TIMP-4) that inhibit MMP activity through 1:1 non-covalent complexes. Regulation occurs via transcriptional factors like TGF-β and epigenetic modifications. Over 10 papers from the list detail TIMP-MMP dynamics in disease contexts, with Bonnans et al. (2014) cited 4149 times.

Curated Papers

Key Challenges

Why It Matters

TIMP regulation modulates ECM remodeling in cancer, atherosclerosis, and arthritis, where MMP-TIMP imbalance drives tissue invasion and plaque instability (Bonnans et al., 2014; Galis et al., 1994). In tumors, TIMPs influence angiogenesis via MMP-9 activation of TGF-β (Yu and Stamenkovic, 2000). Therapeutic targeting of TIMP expression improves inhibitor efficacy in arthritis and vascular diseases (Peter, 2006; Cabral-Pacheco et al., 2020).

Key Research Challenges

Context-Specific TIMP Expression

TIMP levels vary by tissue and disease stage, complicating universal models (Vu and Werb, 2000). TGF-β induces TIMP expression but MMPs degrade it, creating feedback loops (Edwards et al., 1987). Over 1200-citation paper by Vu and Werb (2000) highlights transgenic mouse data showing TIMP knockout phenotypes.

Therapeutic MMP-TIMP Modulation

Synthetic TIMP mimetics face off-target effects on non-MMP proteases (Baker et al., 2002). Clinical trials show variable efficacy due to endogenous regulation (Cabral-Pacheco et al., 2020). Baker et al. (2002, 1161 citations) reviews tissue-specific delivery challenges.

Epigenetic Control Mechanisms

DNA methylation and histone changes regulate TIMP promoters, but assays lack high-throughput (Bonnans et al., 2014). Disease models reveal hypoxia-induced TIMP-1 upregulation in plaques (Galis et al., 1994). Bonnans et al. (2014) cites 4149 times the need for integrated epigenomic profiling.

Essential Papers

Remodelling the extracellular matrix in development and disease

Caroline Bonnans, Jonathan Chou, Zena Werb · 2014 · Nature Reviews Molecular Cell Biology · 4.1K citations

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Zorina S. Galis, Galina K. Sukhova, Michael W. Lark et al. · 1994 · Journal of Clinical Investigation · 2.5K citations

Dysregulated extracellular matrix (ECM) metabolism may contribute to vascular remodeling during the development and complication of human atherosclerotic lesions. We investigated the expression of ...

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis

Qin Yu, Ivan Stamenkovic · 2000 · Genes & Development · 1.7K citations

We have uncovered a novel functional relationship between the hyaluronan receptor CD44, the matrix metalloproteinase-9 (MMP-9) and the multifunctional cytokine TGF-β in the control of tumor-associa...

Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

Alex Y. Strongin, Ivan E. Collier, G. A. Bannikov et al. · 1995 · Journal of Biological Chemistry · 1.6K citations

Matrix metalloproteases are secreted by mammalian cells as zymogens and, upon activation, initiate tissue remodeling by proteolytic degradation of collagens and proteoglycans. Activation of the sec...

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

Griselda A. Cabral-Pacheco, Idalia Garza‐Veloz, Claudia Castruita-De la Rosa et al. · 2020 · International Journal of Molecular Sciences · 1.6K citations

Matrix metalloproteinases (MMPs) are a family of zinc-dependent extracellular matrix (ECM) remodeling endopeptidases that have the capacity to degrade almost every component of the ECM. The degrada...

Matrix Metalloproteinases: Role In Arthritis

Silke Peter · 2006 · Frontiers in bioscience · 1.3K citations

The irreversible destruction of the cartilage, tendon, and bone that comprise synovial joints is the hallmark of both rheumatoid arthritis (RA) and osteoarthritis (OA). While cartilage is made up o...

Matrix metalloproteinases: effectors of development and normal physiology

Thiennu H. Vu, Zena Werb · 2000 · Genes & Development · 1.2K citations

The matrix metalloproteinase (MMP) family of extracellular proteinases regulates development and physiologic events. Genetic analyses using transgenic mice that have gain and loss of function of MM...

Reading Guide

Foundational Papers

Start with Bonnans et al. (2014, 4149 citations) for ECM-TIMP overview, then Galis et al. (1994, 2520 citations) for disease expression patterns, and Vu and Werb (2000, 1231 citations) for genetic models establishing TIMP roles.

Recent Advances

Cabral-Pacheco et al. (2020, 1571 citations) summarizes human diseases; Baker et al. (2002, 1161 citations) covers therapeutic inhibitors; Peter (2006, 1286 citations) details arthritis applications.

Core Methods

Zymogen activation assays (Strongin et al., 1995); TGF-β modulation (Edwards et al., 1987); cell surface proteolysis (Yu and Stamenkovic, 2000); transgenic knockouts (Vu and Werb, 2000).

How PapersFlow Helps You Research Tissue Inhibitors of Metalloproteinases Regulation

Discover & Search

Research Agent uses searchPapers and exaSearch to find TIMP regulation papers like 'Matrix metalloproteinases: effectors of development and normal physiology' by Vu and Werb (2000), then citationGraph reveals 1231 downstream citations on TIMP knockouts, while findSimilarPapers uncovers related works on TGF-β modulation (Edwards et al., 1987).

Analyze & Verify

Analysis Agent applies readPaperContent to extract TIMP-MMP binding affinities from Strongin et al. (1995), verifies claims with CoVe chain-of-verification against 250M+ OpenAlex papers, and uses runPythonAnalysis for statistical comparison of expression data from Galis et al. (1994) plaques vs. controls, graded by GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in TIMP arthritis regulation beyond Peter (2006) and flags contradictions in MMP activation models, while Writing Agent uses latexEditText, latexSyncCitations for Bonnans et al. (2014), and latexCompile to generate review sections with exportMermaid diagrams of MMP-TIMP networks.

Use Cases

"Analyze TIMP-1 expression datasets from atherosclerosis papers and plot MMP/TIMP ratios."

Research Agent → searchPapers('TIMP atherosclerosis') → Analysis Agent → readPaperContent(Galis 1994) → runPythonAnalysis(pandas plot ratios) → matplotlib figure of plaque vulnerability metrics.

"Draft LaTeX review on TIMP regulation in cancer with citations and interaction diagram."

Synthesis Agent → gap detection(TIMP cancer) → Writing Agent → latexEditText(structure review) → latexSyncCitations(Bonnans 2014, Yu 2000) → latexCompile → exportMermaid(MMP-TIMP complex flowchart).

"Find GitHub repos with MMP-TIMP simulation code from mechanism papers."

Research Agent → citationGraph(Strongin 1995) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → verified kinetic models for TIMP inhibition.

Automated Workflows

Deep Research workflow scans 50+ MMP-TIMP papers via searchPapers, structures reports on regulation mechanisms from Vu and Werb (2000), with GRADE checkpoints. DeepScan's 7-step analysis verifies TGF-β induction claims (Edwards et al., 1987) across datasets. Theorizer generates hypotheses on TIMP epigenetics from Bonnans et al. (2014) abstracts.

Try Doxa for Tissue Inhibitors of Metalloproteinases Regulation Research

Frequently Asked Questions

What defines TIMP regulation?

TIMP regulation controls expression and secretion of four inhibitors (TIMP-1-4) that form complexes with MMPs to prevent ECM degradation (Vu and Werb, 2000).

What are key methods for studying TIMPs?

Transgenic mouse models assess TIMP loss-of-function (Vu and Werb, 2000); zymography measures MMP activity (Galis et al., 1994); TGF-β stimulation assays track induction (Edwards et al., 1987).

What are seminal papers on TIMP-MMP?

Bonnans et al. (2014, 4149 citations) reviews ECM remodeling; Baker et al. (2002, 1161 citations) details inhibitor actions; Strongin et al. (1995, 1581 citations) elucidates activation mechanisms.

What open problems exist in TIMP research?

Therapeutic delivery of TIMPs avoids off-target effects (Baker et al., 2002); context-specific expression predictors are lacking (Bonnans et al., 2014); epigenetic regulators need high-throughput mapping.